Tocqueville Asset Management L.P. T Scan Therapeutics, Inc. Transaction History
Tocqueville Asset Management L.P.
- $6.27 Billion
- Q4 2024
A detailed history of Tocqueville Asset Management L.P. transactions in T Scan Therapeutics, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 260,870 shares of TCRX stock, worth $393,913. This represents 0.01% of its overall portfolio holdings.
Number of Shares
260,870
Previous 205,730
26.8%
Holding current value
$393,913
Previous $1.02 Million
23.14%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding TCRX
# of Institutions
89Shares Held
40.9MCall Options Held
0Put Options Held
0-
Lynx1 Capital Management LP San Juan, PR5.36MShares$8.09 Million6.28% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5MShares$7.55 Million0.71% of portfolio
-
Black Rock Inc. New York, NY4.46MShares$6.74 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.5MShares$5.29 Million0.02% of portfolio
-
Bvf Inc San Francisco, CA2.99MShares$4.51 Million0.34% of portfolio
About TScan Therapeutics, Inc.
- Ticker TCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,929,800
- Market Cap $28.6M
- Description
- TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...